Sygnia Itrix Initiates Partial Delisting of SYGH Securities on JSE, Redefining ETF Landscape

  • Sygnia Itrix announces partial delisting of 2,500,000 securities from the Sygnia Itrix Solactive Healthcare 150 ETF (SYGH) on the JSE.
  • Delisting takes effect today at an approximate price of ZAR 30.97 per security.
  • The total number of SYGH securities in circulation will be reduced to 16,268,505 after the partial delisting.

In a strategic move, Sygnia Itrix, a leading provider of collective investment schemes, has announced the partial delisting of securities belonging to the Sygnia Itrix Solactive Healthcare 150 ETF (JSE Code: SYGH, ISIN: ZAE000300521) from the Johannesburg Stock Exchange (JSE). Effective today, 2,500,000 securities will be delisted at an approximate price of ZAR 30.97 per security.

With this partial delisting, the total number of SYGH securities in circulation will be reduced, leaving 16,268,505 securities available for trading. Sygnia Itrix operates under the regulations and oversight of the Collective Investment Schemes Control Act of 2002, ensuring compliance with the necessary legal frameworks.

While the exact reasons for the partial delisting were not disclosed, it is believed that Sygnia Itrix is implementing strategic measures to optimize the composition of the ETF’s portfolio or adjust its investment strategy. Companies often delist securities to enhance shareholder value, improve liquidity, or restructure their capital.

The delisting process will undoubtedly impact investors and market participants, as changes in the supply of listed securities can influence market dynamics. It remains to be seen how this move will affect trading volumes, liquidity, and price movements for the remaining SYGH securities. However, it is crucial to note that the delisting does not necessarily indicate a negative outlook for the ETF but rather reflects Sygnia Itrix’s strategic decisions.

As industry experts and investors closely monitor the developments, the impact of this strategic move on the SYGH ETF’s performance and future prospects will be under scrutiny. With the global healthcare sector gaining prominence, the Sygnia Itrix Solactive Healthcare 150 ETF remains an attractive investment option for those interested in capitalizing on this industry’s growth.

Visited 1 times, 1 visit(s) today

Stay ahead in the financial world – Sign Up to Rateweb’s essential newsletter for free. Get the latest insights on business trends, tech innovations, and market movements, directly to your inbox. Join our community of savvy readers and never miss an update that could impact your financial decisions.

Do you have a news tip for Rateweb reporters? Please email us at


Start trading with a free $30 bonus

Trade stocks, forex, commodities, metals and CFDs on stock indices with an internationally licensed and regulated broker. For all clients who open their first real account, XM offers a $30 trading bonus without any initial deposit needed. Learn more about how you can trade over 1000 instruments on the XM MT4 and MT5 platforms from your PC and Mac, or from a variety of mobile devices.


Personal Financial Tools

Below is a list of tools built to assist South Africans to make the best financial decisions:



South Africa’s primary source of financial tools and information

Contact Us


Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.